Insulin Pumps Market Size Worth over USD 13.5 Billion in 2035 | Roots Analysis

Over the years, insulin pumps have had a major impact on the pharmaceutical industry, primarily due to their ability to simplify insulin delivery process, while maintaining accuracy.

Further, insulin pumps allow fewer injections (when compared to conventional insulin delivery solutions), convenient use (as there is no requirement to carry separate delivery devices) and flexibility in lifestyle of the diabetic patients (by easily managing insulin during meals and exercise).

The insulin pumps market is anticipated to be worth USD 5.8 billion in 2024 and this value is likely to reach over USD 13.6 billion by 2035, expanding at a CAGR of 8% according to a new report by Roots Analysis.

Key Report Takeaways

Currently, more than 40 insulin pumps are available in the market / being developed; it is worth mentioning that close to 30% of the insulin pumps available in the market were launched post-2020.

Majority (~40%) of the insulin pump manufacturers are mid-sized companies; further, around 45% most (43%) of the players in this domain are headquartered in North America (specifically in the US).

An exhaustive set of company profiles of leading players providing valuable insights into their current portfolio and future initiatives.

Since 2021, more than 1,600 patents related to insulin pumps have been filed by / granted to various industry and non-industry players, highlighting the rising intellectual capital in this domain.

The future opportunity within this domain is likely to be well distributed across different segments, such as type of pump, degree of automation, usability of pump, type of battery, type of diabetes targeted, distribution channel and geographical regions.

Competitive Landscape:

The insulin pumps landscape features over 40 insulin pumps that are either available or currently under development for the management of diabetes. Majority (over 60%) of the insulin pumps are patch pumps; these pumps directly adhere to the patients skin and deliver insulin through a cannula. Further, patch pumps are designed to be worn comfortably and decrease the requirement for multiple units. It is worth mentioning that 30% of the insulin pumps are being used for delivery of insulin in patients suffering from Type 1 Diabetes.

Regional Outlook

Based on the key geographical regions, the insulin pumps market can be segmented into five major regions, including North America, Europe, Asia Pacific, Middle East and North Africa, and Latin America. Notably, North America is anticipated to dominate the insulin pumps market in 2024 and this trend is likely to remain unchanged during the forecast period.

Further, Asia Pacific is accounted to be the fastest-growing segment of the insulin pumps market. The growth of the insulin pumps markets in the region is driven by the increasing prevalence of diabetes, along with growing awareness among patients and healthcare providers for these devices.

Insulin Pumps Market Key Players

Examples of key companies engaged in insulin pumps market (which have also been profiled in this market report; the complete list of companies is available in the full report) include:

Beta Bionics

CeQur

EOFlow

Insulet Corporation

LA Roche

MannKind

Medtrum Technologies

MicroPort

Microtech Medical

SOOIL Development

Tandem Diabetes Care

Terumo

ViCentra

Ypsomed

It is interesting to note that in June 2024, Insulet announced the commercial launch of Omnipod 5 Automated Insulin Delivery (AID) System in the UK and Netherlands for individuals aged two years and older suffering from type 1 diabetes. Further, in May 2024, Medtronic entered into a product / technology integration agreement with Arecor to develop implantable insulin pumps.

Insulin Pumps Market Segments

Based on the research, Roots Analysis has segmented the Insulin Pumps Market into Type of Pump, Degree of Automation, Type of Battery, Type of Diabetes Targeted, Distribution Channel and Geography.

by Type of Pump

Tethered Pumps

Patch Pumps

by Degree of Automation

Manual Pumps

Automated / Smart Pumps

by Type of Battery

Replaceable Batteries

Rechargeable Batteries

by Type of Diabetes Targeted

Type 1 Diabetes

Type 2 Diabetes

by Distribution Channel

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Other Pharmacies

by Geography

North America

Europe

Asia-Pacific

Latin America

Middle East and North Africa

About Roots Analysis

Roots Analysis is a global leader in the market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact US

Gaurav Chaudhary

Email: sales@rootsanalysis.com